These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Severe and refractory Clostridium difficile infection successfully treated with tigecycline and metronidazole. Lu CL; Liu CY; Liao CH; Huang YT; Wang HP; Hsueh PR Int J Antimicrob Agents; 2010 Mar; 35(3):311-2. PubMed ID: 20045292 [No Abstract] [Full Text] [Related]
26. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting. Venugopal AA; Riederer K; Patel SM; Szpunar S; Jahamy H; Valenti S; Shemes SP; Khatib R; Johnson LB Scand J Infect Dis; 2012 Apr; 44(4):243-9. PubMed ID: 22077148 [TBL] [Abstract][Full Text] [Related]
28. The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection. Bartlett JG Clin Infect Dis; 2008 May; 46(10):1489-92. PubMed ID: 18419480 [No Abstract] [Full Text] [Related]